Open Access Research
Novel anticancer mechanisms of JinYingZi-derived oleanolic acid against renal cell carcinoma: an in silico analysis
Ismael Obaidi1,2
, Fatimah Adnan Alzubaidi2, Aymen A. Bash2, Qayssar Joudah Fadheel2, Hussam W. Al-Humadi2, Junying Liu1,*
1NatPro Centre for Natural Products Research, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland
2College of Pharmacy, University of Babylon, Hillah, Iraq
*Corresponding author: Junying Liu, NatPro Centre for Natural Products Research, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland; Tel.: +353-(0)871233798
E-mail: juliu@tcd.ie
Download PDF
Published: 5 May 2024; https://doi.org/10.61873/KZWS3688
Abstract
Renal cell carcinoma (RCC) is the most common type of kidney cancer, accounting for 90% of all estimated cases. Advanced RCC often carries poor prognosis due to its high metastases rate, the lack of early-warning signs, as well as its complex clinical manifestations and its resistance to chemotherapy. Ethnopharmacologically, Fructus Rosae laevigata (JinYingZi) has been employed by Chinese medicine to treat various urinary tract and gastrointestinal disorders. This study aimed at performing a series of mechanistic analyses in order to unlock the anticancer potential of JinYingZi-derived bioactive components against RCC. Several network pharmacology tools were employed so as to analyse the drug-disease interactions. Our data revealed that more than 2,214 genes were dysregulated in RCC, whereas the JinYingZi-derived bioactive compounds modulated 347 genes. The intersecting between RCC and the bioactive compounds revealed 132 cross targets. Our results were further validated by conducting molecular docking, which revealed a stable association between oleanolic acid with each of the following targets: androgen receptor (AR), dipeptidyl peptidase (DPP), estradiol (ESR1), nitric oxide synthase 2 (NOS2), and cyclooxygenase-2 (PTGS2). Our approach is being used successfully in order to evaluate a panel of novel medicinal plant-derived bioactive compounds, and may lead to the identification of safe and effective chemical scaffolds that could act as templates for drug discovery or yield potential drug candidates.
Keywords: renal cell carcinoma, JinYingZi, oleanolic acid, network pharmacology, molecular docking
Please cite as:
Obaidi I., Alzubaidi F.A., Bash A.A., Fadheel Q.J., Al-Humadi H.W., Liu J. Novel anticancer mechanisms of JinYingZi-derived oleanolic acid against renal cell carcinoma: an in silico analysis. Rev. Clin. Pharmacol. Pharmacokinet. Int. Ed. 38(Sup2): 157-160 (2024). https://doi.org/10.61873/KZWS3688